Hypoxia significantly impacts SFs' crosstalk with Th cells, altering RA pathophysiology by reducing SFs' ability to restrain Th cell proliferation, decreasing MMP-3, IL-6, IL-10, and IFNγ expression, and increasing IL-17A levels [109]. This evidence concerns the gene IL6 and rheumatoid arthritis.